BOSTON, Oct. 7 /PRNewswire/ -- The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce the full agenda for the upcoming Biotech/Pharma Finance and Accounting Forum in San Francisco on November 19, 2009. Marc J. Fagel, Regional Director of the San Francisco Regional Office at the U.S. Securities and Exchange Commission, is the most recent addition to the program's elite faculty and will address SEC enforcement and the review process.
This comprehensive one-day forum delves into the accounting and biotech financial reporting issues that matter most during these tough economic times and, in addition to the SEC, will include presentations from firms such as Cell Genesys, Affymax, BioMarin Pharmaceuticals, Monogram Biosciences, Inc., Oncomed and Poniard Pharmaceuticals. Over 2,400 executives have attended CBI's Pharmaceutical Accounting and Financial Reporting Congress since its inception more than five years ago, and this year's San Francisco program has been specifically designed for innovative life science companies.
Other opportune session topics include:
CBI's west coast forum is sponsored by PricewaterhouseCoopers, Duff & Phelps, OUM & Co LLP and KPMG. To view the full agenda, please visit http://www.cbinet.com/agendawest. If you would like to apply for a press pass, please contact Erica Kirwan of CBI at 339.298.2263.
A subsidiary of Advanstar Communications, CBI Research, Inc. offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy- and decision-makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit http://www.cbinet.com.
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
SOURCE The Center for Business Intelligence
|SOURCE The Center for Business Intelligence|
Copyright©2009 PR Newswire.
All rights reserved